December 12, 2024

Innovation Prize 2025 of the German BioRegions – Application Deadline: February 14, 2025

Innovation Prize 2025 of the German BioRegions – Application Deadline: February 14, 2025
Go back

Innovators wanted. APPLY NOW!
WE SUPPORT YOUR INNOVATIVE INVENTION!

The work group of the BioRegions in Germany is the central network of regional initiatives promoting the economic use of modern biotechnologies in Germany. It annually awards the Innovation Prize of the BioRegions in Germany. This year, the work group again recognizes application-oriented ideas with strong implementation potential and showcases them at the German Biotech Days.

What is awarded?

  • The Innovation Prize honors innovative ideas that are patented or have been submitted for patenting.
  • We seek application-oriented ideas with strong implementation potential and high market opportunities.
  • Our aim is to support outstanding innovations that can significantly contribute to the economy and society.

Who can apply?

  • Scientists from universities and non-university institutions
  • Legal entities under public law, such as universities, universities of applied sciences, or patent exploitation agencies
  • Founders of companies that have not yet generated significant revenue and have not transferred substantial company shares to external investors

What do we offer?

  • Invitation for six finalists to the German Biotech Days on April 9 and 10, 2025, in Heidelberg
  • Presentation to an international audience, financiers, and the trade press
  • Three awards, each worth €2,000
  • An audience award worth €2,000

Apply now!

Application Deadline: February 14, 2025.

TO THE APPLICATION
Innopreis_2025_Flyer_EDownload

Our latest News

discover more
Heidelberg Medical Students Remain at the Very Top in Germany

Heidelberg Medical Students Remain at the Very Top in Germany

In the first phase of the medical exams, students at Heidelberg University’s Faculty of Medicine once again achieved excellent results: In the so-called “Physikum,” the state exam in medical theory, they ranked first in Germany—for the fifth consecutive year. Full Text in German below. Heidelberger Medizin-Studierende weiter absolute Spitze in Deutschland Im ersten Abschnitt der […]

read more
Heisenberg Professorship for Aurélie Ernst

Heisenberg Professorship for Aurélie Ernst

With funding from the German Research Foundation’s (DFG) Heisenberg Program, DKFZ researcher Aurélie Ernst aims to investigate how massive changes in the genome contribute to the development of cancer. Her research focuses on a phenomenon known as chromothripsis – a catastrophic event in the genome in which chromosomes break apart and are reassembled incorrectly. In […]

read more
New Publication by Gen-H: Multi-plasmid antibiotic-free fermentation

New Publication by Gen-H: Multi-plasmid antibiotic-free fermentation

Our latest publication demonstrates a robust strategy for antibiotic-free maintenance of multiple plasmids using orthogonal conditional complementation. You can read the article here. Key highlights: ✅ Maintenance of two plasmids without antibiotics or resistance markers✅ Functionality in non-supplemented media✅ Flexible one- or two-plasmid configurations using orthogonal inducible promoters✅ Productivity equivalent or superior to conventional antibiotic-selected […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp